KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Receivables (2020 - 2025)

Historic Receivables for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $1.5 billion.

  • Organon's Receivables fell 1192.88% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 1192.88%. This contributed to the annual value of $1.4 billion for FY2024, which is 2213.3% down from last year.
  • Latest data reveals that Organon reported Receivables of $1.5 billion as of Q3 2025, which was down 1192.88% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Organon's Receivables registered a high of $2.5 billion during Q2 2021, and its lowest value of $1.0 billion during Q1 2021.
  • For the 5-year period, Organon's Receivables averaged around $1.7 billion, with its median value being $1.7 billion (2022).
  • Within the past 5 years, the most significant YoY rise in Organon's Receivables was 6633.66% (2022), while the steepest drop was 2321.72% (2022).
  • Quarter analysis of 5 years shows Organon's Receivables stood at $1.8 billion in 2021, then increased by 3.59% to $1.8 billion in 2022, then dropped by 5.68% to $1.7 billion in 2023, then decreased by 22.13% to $1.4 billion in 2024, then grew by 9.28% to $1.5 billion in 2025.
  • Its Receivables stands at $1.5 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.5 billion for Q1 2025.